These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 29429948)

  • 1. Virtual-reality-based cognitive behavioural therapy versus waiting list control for paranoid ideation and social avoidance in patients with psychotic disorders: a single-blind randomised controlled trial.
    Pot-Kolder RMCA; Geraets CNW; Veling W; van Beilen M; Staring ABP; Gijsman HJ; Delespaul PAEG; van der Gaag M
    Lancet Psychiatry; 2018 Mar; 5(3):217-226. PubMed ID: 29429948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual reality cognitive-behavioural therapy versus cognitive-behavioural therapy for paranoid delusions: a study protocol for a single-blind multi-Centre randomised controlled superiority trial.
    Berkhof M; van der Stouwe ECD; Lestestuiver B; Van't Hag E; van Grunsven R; de Jager J; Kooijmans E; Zandee CER; Staring ABP; Pot-Kolder RMCA; Vos M; Veling W
    BMC Psychiatry; 2021 Oct; 21(1):496. PubMed ID: 34635063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Virtual Reality Cognitive Behavioral Therapy for Psychosis: Health-Economic Evaluation Within a Randomized Controlled Trial.
    Pot-Kolder R; Veling W; Geraets C; Lokkerbol J; Smit F; Jongeneel A; Ising H; van der Gaag M
    J Med Internet Res; 2020 May; 22(5):e17098. PubMed ID: 32369036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Face Your Fears: Virtual reality-based cognitive behavioral therapy (VR-CBT) versus standard CBT for paranoid ideations in patients with schizophrenia spectrum disorders: a randomized clinical trial.
    Jeppesen UN; Due AS; Mariegaard L; Pinkham A; Vos M; Veling W; Nordentoft M; Glenthøj LB
    Trials; 2022 Aug; 23(1):658. PubMed ID: 35971137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cognitive behaviour therapy for worry on persecutory delusions in patients with psychosis (WIT): a parallel, single-blind, randomised controlled trial with a mediation analysis.
    Freeman D; Dunn G; Startup H; Pugh K; Cordwell J; Mander H; Černis E; Wingham G; Shirvell K; Kingdon D
    Lancet Psychiatry; 2015 Apr; 2(4):305-13. PubMed ID: 26360083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.
    Morrison AP; Law H; Carter L; Sellers R; Emsley R; Pyle M; French P; Shiers D; Yung AR; Murphy EK; Holden N; Steele A; Bowe SE; Palmier-Claus J; Brooks V; Byrne R; Davies L; Haddad PM
    Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VR-SOAP, a modular virtual reality treatment for improving social activities and participation of young people with psychosis: a study protocol for a single-blind multi-centre randomized controlled trial.
    Meins IA; Muijsson-Bouwman DC; Nijman SA; Greaves-Lord K; Veling W; Pijnenborg GHM; van der Stouwe ECD
    Trials; 2023 Apr; 24(1):278. PubMed ID: 37061694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated psychological therapy using virtual reality (VR) for patients with persecutory delusions: study protocol for a single-blind parallel-group randomised controlled trial (THRIVE).
    Freeman D; Lister R; Waite F; Yu LM; Slater M; Dunn G; Clark D
    Trials; 2019 Jan; 20(1):87. PubMed ID: 30696471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Interactive Social Cognition Training in Virtual Reality (DiSCoVR) for social cognition and social functioning in people with a psychotic disorder: study protocol for a multicenter randomized controlled trial.
    Nijman SA; Veling W; Greaves-Lord K; Vermeer RR; Vos M; Zandee CER; Zandstra DC; Geraets CNW; Pijnenborg GHM
    BMC Psychiatry; 2019 Sep; 19(1):272. PubMed ID: 31488103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analyses.
    Freeman D; Lambe S; Kabir T; Petit A; Rosebrock L; Yu LM; Dudley R; Chapman K; Morrison A; O'Regan E; Aynsworth C; Jones J; Murphy E; Powling R; Galal U; Grabey J; Rovira A; Martin J; Hollis C; Clark DM; Waite F;
    Lancet Psychiatry; 2022 May; 9(5):375-388. PubMed ID: 35395204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subjective experience of paranoid ideation in a virtual reality social environment: A mixed methods cross-sectional study.
    Riches S; Bird L; Chan N; Garety P; Rus-Calafell M; Valmaggia L
    Clin Psychol Psychother; 2020 May; 27(3):337-345. PubMed ID: 31994786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual reality based cognitive behavioral therapy for paranoia: Effects on mental states and the dynamics among them.
    Geraets CNW; Snippe E; van Beilen M; Pot-Kolder RMCA; Wichers M; van der Gaag M; Veling W
    Schizophr Res; 2020 Aug; 222():227-234. PubMed ID: 32527676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the role of clinical and demographic characteristics on the effects of virtual reality cognitive behavioral therapy for psychosis: A moderator analysis.
    Berkhof M; van der Stouwe ECD; Pot-Kolder RMCA; van der Gaag M; Veling W; Geraets CNW
    Acta Psychiatr Scand; 2024 Jun; ():. PubMed ID: 38853472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange).
    Freeman D; Yu LM; Kabir T; Martin J; Craven M; Leal J; Lambe S; Brown S; Morrison A; Chapman K; Dudley R; O'Regan E; Rovira A; Goodsell A; Rosebrock L; Bergin A; Cryer TL; Robotham D; Andleeb H; Geddes JR; Hollis C; Clark DM; Waite F
    BMJ Open; 2019 Aug; 9(8):e031606. PubMed ID: 31462489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary study of effects on paranoia ideation and jumping to conclusions in the context of group treatment of anxiety disorders in young people.
    Giusti L; Ussorio D; Salza A; Malavolta M; Aggio A; Bianchini V; Casacchia M; Roncone R
    Early Interv Psychiatry; 2018 Dec; 12(6):1072-1080. PubMed ID: 28124444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Self-guided App-Based Virtual Reality Cognitive Behavior Therapy for Acrophobia: A Randomized Clinical Trial.
    Donker T; Cornelisz I; van Klaveren C; van Straten A; Carlbring P; Cuijpers P; van Gelder JL
    JAMA Psychiatry; 2019 Jul; 76(7):682-690. PubMed ID: 30892564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of virtual reality exposure therapy on social participation in people with a psychotic disorder (VRETp): study protocol for a randomized controlled trial.
    Pot-Kolder R; Veling W; Geraets C; van der Gaag M
    Trials; 2016 Jan; 17():25. PubMed ID: 26762123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual reality compared with
    Bouchard S; Dumoulin S; Robillard G; Guitard T; Klinger É; Forget H; Loranger C; Roucaut FX
    Br J Psychiatry; 2017 Apr; 210(4):276-283. PubMed ID: 27979818
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
    Olthuis JV; Watt MC; Bailey K; Hayden JA; Stewart SH
    Cochrane Database Syst Rev; 2015 Mar; (3):CD011565. PubMed ID: 25742186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.